ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business

Nobel laureate asks Fujifilm to keep licensing fees low

Stem cell pioneer wary of patent fees impeding regenerative medicine

Building a stock of induced pluripotent stem cells is a public service project, said professor Shinya Yamanaka of Kyoto University.

TOKYO -- A noted Japanese stem cell researcher has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells, he told The Nikkei on Wednesday.

Shinya Yamanaka, director of the Center for iPS Cell Research and Application at Kyoto University, intends to negotiate with Fujifilm. Yamanaka -- who won the Nobel Prize in physiology or medicine in 2012 for his work on iPS cells -- sees the relevant patents as crucial to the field of regenerative medicine and fears that steep licensing fees will hinder progress. Attention will now be on how the Tokyo-based company responds.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more